Breakthrough Victoria shells out $12 million for peanut allergy treatment developer Aravax

The Victorian government-funded Breakthrough Victoria has made a $12 million investment into Aravax, part of a $66 million funding round in the biotechnology company, which is developing a novel peanut allergy treatment. Aravax is a clinical-stage company developing PVX108, its immunotherapy product that uses synthetic peptides to mimic key parts of peanut proteins to retrain…

Applications open for Energy Technologies Manufacturing program

Applications are open for grants worth between $100,000 and $750,000 under the Victorian government’s Made in Victoria – Energy Technologies Manufacturing program. According to a statement on Wednesday from industry minister Natalie Hutchins, grants will support manufacturers of products or components for zero emissions and renewable energy in purchasing or developing new equipment, skills, or…

State government announces funding for commercialising university research

The Victorian government has announced new co-investment partnerships with five Victorian universities, with $87 million in total to be allocated through the Breakthrough Victoria – University Innovation Platform program  The new partnerships are with Deakin University, La Trobe University, Monash University, RMIT University and Swinburne University, and according to industry minister Ben Carroll “will help…

Moderna’s Monash mRNA factory now half-built

The Victorian government has announced that construction of Moderna’s mRNA vaccine manufacturing facility is ahead of schedule and at the halfway mark, with completion expected next year. State industry minister Ben Carroll visited Monash University’s Clayton precinct on Monday morning, where the US-based biotechnology company will eventually have capacity for 100 million vaccine doses per…

Best of the week — the five most popular stories among @AuManufacturing’s readers

What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Neo-Bionica launches onshore critical medical manufacturing process Advanced MedTech contract manufacturer Neo-Bionica has revealed the expansion of its manufacturing services with the launch of its new hermitization capability – a first for Australian industry. Hermitization is a critical…